window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital Health

  • Clinical Development,Clinical Trials,Digital Health,Partnerships & Funding,Technology and platforms

    Trialbee secures majority investment from Varsity Healthcare Partners to scale patient recruitment

    Trialbee has secured a majority growth investment from Varsity Healthcare [...]

    January 8, 2026
  • Clinical Development,Clinical studies,Clinical Trials,Data Management,Digital Health,Drug Development,Regulatory Affairs,Technology and platforms

    CluePoints: how proactive oversight and AI are reshaping clinical trial data management

    Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

    January 7, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Digital Health,Medical devices,Technology and platforms

    12th Day of Christmas: Ledger Run and AcuityMD predict AI will drive operational change across clinical trials and MedTech in 2026

    On the 12th Day of Christmas in Discover Pharma’s industry [...]

    January 5, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Digital Health,Regulatory Affairs,Technology and platforms

    11th Day of Christmas: Medable predicts agentic AI will reshape clinical trials and regulation in 2026

    On the 11th Day of Christmas in Discover Pharma’s industry [...]

    December 31, 2025
  • Artificial Intelligence,Clinical Trials,Data Management,Digital Health,Patient Centricity

    Nine ladies dancing: uMotif – patient-centric trials and AI take centre stage in 2026

    As part of Discover Pharma’s 12 days of Christmas series, [...]

    December 22, 2025
  • CDMOs & Manufacturing,Clinical Development,Digital Health,Market Access & Commercialization,Patient Centricity

    Seven lords a-leaping: Gifthealth CEO on why DTP must blend high tech with high touch in 2026

    For Seven lords a-leaping, Discover Pharma turns to Chip Parkinson, [...]

    December 18, 2025
  • Clinical Development,Data Management,Digital Health,Regulatory Affairs,Technology and platforms

    PHARMASEAL: five gold rings that shaped clinical operations in 2025

    Like the five gold rings in the Christmas carol, 2025 [...]

    December 18, 2025
  • Clinical Trials,Data Management,Digital Health,Patient Centricity

    uMotif: patient-centricity took flight again in 2025 like four calling birds

    In 2025, patient-centricity, just like the four calling birds soared [...]

    December 18, 2025
  • Digital Health,FDA,Medical devices,Mental health

    FDA approves first at-home non-drug treatment for depression

    US regulators have authorised the first at-home brain-stimulation treatment for [...]

    December 12, 2025
  • Digital Health

    AmeriTrust founder Peter Justen to receive healthcare innovation award at Oxford summit

    AmeriTrust Solutions founder Peter Justen will be recognised in Oxford [...]

    December 11, 2025
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top